Biostealth Fluid Technology: Transforming medical care worldwide.
SCROLL DOWN
SCROLL DOWN
Biostealth Fluid Technology: Transforming medical care worldwide.
Our Platform Overview
SCROLL DOWN
SCROLL DOWN
Biostealth Fluid Technology: Transforming medical care worldwide.
SCROLL DOWN
SCROLL DOWN
Tetramatrix: Our Biostealth Fluid Technology
Tetramatrix™ is a biostealth fluid technology engineered to transition at physiological temperature and form a tissue-adhering 3D matrix after delivery. Designed as a single platform it can be adapted to distinct derivatives for different tissues, indications and delivery requirements without reinventing the underlying system each time.
•
Minimally invasive delivery
Water-based solution that can be injected or sprayed into the body without causing disruption to the surrounding host tissue.
•
Seamlessly integrates into existing clinical workflows
Engineered for predictable point-of-care handling without bespoke infrastructure, controlled transition at physiological temperature for repeatable, measurable and clinically practical performance shown in clinical studies.
•
Biostealth: engineered to be ignored
With seamless biocompatibility, Tetramatrix™ works with the body then resorbs with no fuss, no noise and nothing left behind.
•
Manufactured at low cost and at scale
Built with manufacturability, robust quality systems and scalability in mind, Tetramatrix™ supports clear pathways from development through to validation and ultimately real-world clinical deployment.
Tetramatrix: Our Biostealth Fluid Technology
Tetramatrix™ is a biostealth fluid technology engineered to transition at physiological temperature and form a tissue-adhering 3D matrix after delivery. Designed as a single platform it can be adapted to distinct derivatives for different tissues, indications and delivery requirements without reinventing the underlying system each time.
•
Minimally invasive delivery
Water-based solution that can be injected or sprayed into the body without causing disruption to the surrounding host tissue.
•
Seamlessly integrates into existing clinical workflows
Engineered for predictable point-of-care handling without bespoke infrastructure, controlled transition at physiological temperature for repeatable, measurable and clinically practical performance shown in clinical studies.
•
Biostealth: engineered to be ignored
With seamless biocompatibility, Tetramatrix™ works with the body then resorbs with no fuss, no noise and nothing left behind.
•
Manufactured at low cost and at scale
Built with manufacturability, robust quality systems and scalability in mind, Tetramatrix™ supports clear pathways from development through to validation and ultimately real-world clinical deployment.
Tetramatrix: Our Biostealth Fluid Technology
Tetramatrix™ is a biostealth fluid technology engineered to transition at physiological temperature and form a tissue-adhering 3D matrix after delivery. Designed as a single platform it can be adapted to distinct derivatives for different tissues, indications and delivery requirements without reinventing the underlying system each time.
•
Minimally invasive delivery
Water-based solution that can be injected or sprayed into the body without causing disruption to the surrounding host tissue.
•
Seamlessly integrates into existing clinical workflows
Engineered for predictable point-of-care handling without bespoke infrastructure, controlled transition at physiological temperature for repeatable, measurable and clinically practical performance shown in clinical studies.
•
Biostealth: engineered to be ignored
With seamless biocompatibility, Tetramatrix™ works with the body then resorbs with no fuss, no noise and nothing left behind.
•
Manufactured at low cost and at scale
Built with manufacturability, robust quality systems and scalability in mind, Tetramatrix™ supports clear pathways from development through to validation and ultimately real-world clinical deployment.
Why we exist
We use the modularity of the Tetramatrix™ platform to partner with key market leaders to develop new technologies and together maximise impact. We make product development more efficient; patients and physicians can access the future of healthcare sooner.
Rising patient expectations
Patients are increasingly expecting higher quality of care with a particular focus on reducing recovery times and the lower risk of complications - which is also a driver of increasing healthcare costs for patients and payers globally.
Need for cost-effective and decentralised care
Increasing global healthcare spending and demand for healthcare services are necessitating investment in cost-effective tools and treatments, including those that can be delivered outside a traditional hospital setting, to minimise burden on the healthcare system.
Easier healthcare delivered wherever care happens
Consumers are taking a bigger role in healthcare choices, they are demanding safer, easier options they can use at home or assisted in outpatient settings focused on predictable performance that improves access and outcomes.
Why we exist
We use the modularity of the Tetramatrix™ platform to partner with key market leaders to develop new technologies and together maximise impact. We make product development more efficient; patients and physicians can access the future of healthcare sooner.
Rising patient expectations
Patients are increasingly expecting higher quality of care with a particular focus on reducing recovery times and the lower risk of complications - which is also a driver of increasing healthcare costs for patients and payers globally.
Need for cost-effective and decentralised care
Increasing global healthcare spending and demand for healthcare services are necessitating investment in cost-effective tools and treatments, including those that can be delivered outside a traditional hospital setting, to minimise burden on the healthcare system.
Easier healthcare delivered wherever care happens
Consumers are taking a bigger role in healthcare choices, they are demanding safer, easier options they can use at home or assisted in outpatient settings focused on predictable performance that improves access and outcomes.
Why we exist
We use the modularity of the Tetramatrix™ platform to partner with key market leaders to develop new technologies and together maximise impact. We make product development more efficient; patients and physicians can access the future of healthcare sooner.
Rising patient expectations
Patients are increasingly expecting higher quality of care with a particular focus on reducing recovery times and the lower risk of complications - which is also a driver of increasing healthcare costs for patients and payers globally.
Need for cost-effective and decentralised care
Increasing global healthcare spending and demand for healthcare services are necessitating investment in cost-effective tools and treatments, including those that can be delivered outside a traditional hospital setting, to minimise burden on the healthcare system.
Easier healthcare delivered wherever care happens
Consumers are taking a bigger role in healthcare choices, they are demanding safer, easier options they can use at home or assisted in outpatient settings focused on predictable performance that improves access and outcomes.
How it works
The Tetramatrix™ platform polymer, in development for over a decade, forms a smart and bioresorbable 3D matrix. Its modular design enables plug-and-play solutions across a range of indications and medical uses.
Intelligent
A decade of polymer programming has led to an ideal consistency and physical performance. The Tetramatrix™ platform polymer is an injectable fluid to avoid causing damage to the body during its application. Using physiological temperature, the material transitions into a 3D matrix.
Modular
A biomaterial platform built with unique polymer programming akin to “medical lego” to form implantable products to solve a wide range of clinical problems. TheTetramatrix™ platform has given birth to multiple chemical entities addressing multiple clinical indications at various anatomical sites.
Biomimetic
The matrix has similar water content and mechanical properties to natural tissue, and therefore is imperceptible to the body. Once the matrix serves its purpose, the material gradually and safely bioresorbs in the body with negligible impact locally or systemically.
How it works
The Tetramatrix™ platform polymer, in development for over a decade, forms a smart and bioresorbable 3D matrix. Its modular design enables plug-and-play solutions across a range of indications and medical uses.
Intelligent
A decade of polymer programming has led to an ideal consistency and physical performance. The Tetramatrix™ platform polymer is an injectable fluid to avoid causing damage to the body during its application. Using physiological temperature, the material transitions into a 3D matrix.
Modular
A biomaterial platform built with unique polymer programming akin to “medical lego” to form implantable products to solve a wide range of clinical problems. TheTetramatrix™ platform has given birth to multiple chemical entities addressing multiple clinical indications at various anatomical sites.
Biomimetic
The matrix has similar water content and mechanical properties to natural tissue, and therefore is imperceptible to the body. Once the matrix serves its purpose, the material gradually and safely bioresorbs in the body with negligible impact locally or systemically.
How it works
The Tetramatrix™ platform polymer, in development for over a decade, forms a smart and bioresorbable 3D matrix. Its modular design enables plug-and-play solutions across a range of indications and medical uses.
Intelligent
A decade of polymer programming has led to an ideal consistency and physical performance. The Tetramatrix™ platform polymer is an injectable fluid to avoid causing damage to the body during its application. Using physiological temperature, the material transitions into a 3D matrix.
Modular
A biomaterial platform built with unique polymer programming akin to “medical lego” to form implantable products to solve a wide range of clinical problems. TheTetramatrix™ platform has given birth to multiple chemical entities addressing multiple clinical indications at various anatomical sites.
Biomimetic
The matrix has similar water content and mechanical properties to natural tissue, and therefore is imperceptible to the body. Once the matrix serves its purpose, the material gradually and safely bioresorbs in the body with negligible impact locally or systemically.
Clinical Franchises 001
Bone Regeneration
Bone Regeneration products built upon the Tetramatrix™ platform were designed for dental and orthopaedic applications where graft placement, retention and controlled structure matter. The intent is to provide practical, flowable bone extenders that transition to a matrix designed to support natural tissue response at the defect site. The derived products are tissue conductive and allow host cells to grow within the matrix naturally and therefore facilitate biological integration.
Clinical Franchises 002
Tissue Healing
Tissue Healing products built upon the Tetramatrix™ platform were deliberately designed to physically and biologically integrate with surrounding soft tissue anywhere in the body. This provides a synthetic but biologically inert matrix that forms a bridge that channels new tissue into the existing environment. Already clinically explored for scar reduction / prevention in the world of surgical incisions, this technology has a plethora of clinical applications for healing tissues in other areas including the spine, cartilage and tendon.
Clinical Franchises 003
Tissue Spacing
Tissue Spacing products built upon the Tetramatrix™ platform were developed to create and maintain surgical space in the body to support a range of surgeries or medical interventions. Delivered by simple injection, these products remain visible to clinicians under multiple conditions while their structural stability, resorption and modularity fulfil a range of clinical needs in early development from the optimisation of radiation therapy to microscopic cataract surgeries.
Clinical Franchises 004
Precision Medicine
Our initial Precision Medicine product (STEPP) is built upon the Tetramatrix™ platform creating a sprayable drug delivery system for intranasal delivery of active compounds to provide a clinically reproducible, minimally invasive and easy to use route of administration. STEPP has been shown in early clinical testing to protects the active compound, creates a sticky cushion on the nasal canal and helps to efficiently transport the active compounds into the blood stream.
Clinical Franchises 001
Bone Regeneration
Bone Regeneration products built upon the Tetramatrix™ platform were designed for dental and orthopaedic applications where graft placement, retention and controlled structure matter. The intent is to provide practical, flowable bone extenders that transition to a matrix designed to support natural tissue response at the defect site. The derived products are tissue conductive and allow host cells to grow within the matrix naturally and therefore facilitate biological integration.
Clinical Franchises 002
Tissue Healing
Tissue Healing products built upon the Tetramatrix™ platform were deliberately designed to physically and biologically integrate with surrounding soft tissue anywhere in the body. This provides a synthetic but biologically inert matrix that forms a bridge that channels new tissue into the existing environment. Already clinically explored for scar reduction / prevention in the world of surgical incisions, this technology has a plethora of clinical applications for healing tissues in other areas including the spine, cartilage and tendon.
Clinical Franchises 003
Tissue Spacing
Tissue Spacing products built upon the Tetramatrix™ platform were developed to create and maintain surgical space in the body to support a range of surgeries or medical interventions. Delivered by simple injection, these products remain visible to clinicians under multiple conditions while their structural stability, resorption and modularity fulfil a range of clinical needs in early development from the optimisation of radiation therapy to microscopic cataract surgeries.
Clinical Franchises 004
Precision Medicine
Our initial Precision Medicine product (STEPP) is built upon the Tetramatrix™ platform creating a sprayable drug delivery system for intranasal delivery of active compounds to provide a clinically reproducible, minimally invasive and easy to use route of administration. STEPP has been shown in early clinical testing to protects the active compound, creates a sticky cushion on the nasal canal and helps to efficiently transport the active compounds into the blood stream.
Clinical Franchises 001
Bone Regeneration
Bone Regeneration products built upon the Tetramatrix™ platform were designed for dental and orthopaedic applications where graft placement, retention and controlled structure matter. The intent is to provide practical, flowable bone extenders that transition to a matrix designed to support natural tissue response at the defect site. The derived products are tissue conductive and allow host cells to grow within the matrix naturally and therefore facilitate biological integration.
Clinical Franchises 002
Tissue Healing
Tissue Healing products built upon the Tetramatrix™ platform were deliberately designed to physically and biologically integrate with surrounding soft tissue anywhere in the body. This provides a synthetic but biologically inert matrix that forms a bridge that channels new tissue into the existing environment. Already clinically explored for scar reduction/ prevention in the world of surgical incisions, this technology has a plethora of clinical applications for healing tissues in other areas including the spine, cartilage and tendon.
Clinical Franchises 003
Tissue Spacing
Tissue Spacing products built upon the Tetramatrix™ platform were developed to create and maintain surgical space in the body to support a range of surgeries or medical interventions. Delivered by simple injection, these products remain visible to clinicians under multiple conditions, while their structural stability, resorption and modularity fulfil a range of clinical needs from the optimisation of radiation therapy to microscopic cataract surgeries.
Clinical Franchises 004
Precision Medicine
Our initial Precision Medicine product (STEPP) is built upon the Tetramatrix™ platform creating a sprayable drug delivery system for intranasal delivery of active compounds to provide a clinically reproducible, minimally invasive and easy to use route of administration. STEPP has been shown in early clinical testing to protects the active compound, creates a sticky cushion on the nasal canal and helps to efficiently transport the active compounds into the blood stream.
Clinical Franchises 001
Bone Regeneration
Bone Regeneration products built upon the Tetramatrix™ platform were designed for dental and orthopaedic applications where graft placement, retention and controlled structure matter. The intent is to provide practical, flowable bone extenders that transition to a matrix designed to support natural tissue response at the defect site. The derived products are tissue conductive and allow host cells to grow within the matrix naturally and therefore facilitate biological integration.
Clinical Franchises 002
Tissue Healing
Tissue Healing products built upon the Tetramatrix™ platform were deliberately designed to physically and biologically integrate with surrounding soft tissue anywhere in the body. This provides a synthetic but biologically inert matrix that forms a bridge that channels new tissue into the existing environment. Already clinically explored for scar reduction/ prevention in the world of surgical incisions, this technology has a plethora of clinical applications for healing tissues in other areas including the spine, cartilage and tendon.
Clinical Franchises 003
Tissue Spacing
Tissue Spacing products built upon the Tetramatrix™ platform were developed to create and maintain surgical space in the body to support a range of surgeries or medical interventions. Delivered by simple injection, these products remain visible to clinicians under multiple conditions, while their structural stability, resorption and modularity fulfil a range of clinical needs from the optimisation of radiation therapy to microscopic cataract surgeries.
Clinical Franchises 004
Precision Medicine
Our initial Precision Medicine product (STEPP) is built upon the Tetramatrix™ platform creating a sprayable drug delivery system for intranasal delivery of active compounds to provide a clinically reproducible, minimally invasive and easy to use route of administration. STEPP has been shown in early clinical testing to protects the active compound, creates a sticky cushion on the nasal canal and helps to efficiently transport the active compounds into the blood stream.
Clinical Franchises 001
Bone Regeneration
Bone Regeneration products built upon the Tetramatrix™ platform were designed for dental and orthopaedic applications where graft placement, retention and controlled structure matter. The intent is to provide practical, flowable bone extenders that transition to a matrix designed to support natural tissue response at the defect site. The derived products are tissue conductive and allow host cells to grow within the matrix naturally and therefore facilitate biological integration.
Clinical Franchises 002
Tissue Healing
Tissue Healing products built upon the Tetramatrix™ platform were deliberately designed to physically and biologically integrate with surrounding soft tissue anywhere in the body. This provides a synthetic but biologically inert matrix that forms a bridge that channels new tissue into the existing environment. Already clinically explored for scar reduction / prevention in the world of surgical incisions, this technology has a plethora of clinical applications for healing tissues in other areas including the spine, cartilage and tendon.
Clinical Franchises 003
Tissue Spacing
Tissue Spacing products built upon the Tetramatrix™ platform were developed to create and maintain surgical space in the body to support a range of surgeries or medical interventions. Delivered by simple injection, these products remain visible to clinicians under multiple conditions while their structural stability, resorption and modularity fulfil a range of clinical needs from the optimisation of radiation therapy to microscopic cataract surgeries.
Clinical Franchises 004
Precision Medicine
Our initial Precision Medicine product (STEPP) is built upon the Tetramatrix™ platform creating a sprayable drug delivery system for intranasal delivery of active compounds to provide a clinically reproducible, minimally invasive and easy to use route of administration. STEPP has been shown in early clinical testing to protects the active compound, creates a sticky cushion on the nasal canal and helps to efficiently transport the active compounds into the blood stream.
Clinical Franchises 001
Bone Regeneration
Bone Regeneration products built upon the Tetramatrix™ platform were designed for dental and orthopaedic applications where graft placement, retention and controlled structure matter. The intent is to provide practical, flowable bone extenders that transition to a matrix designed to support natural tissue response at the defect site. The derived products are tissue conductive and allow host cells to grow within the matrix naturally and therefore facilitate biological integration.
Clinical Franchises 002
Tissue Healing
Tissue Healing products built upon the Tetramatrix™ platform were deliberately designed to physically and biologically integrate with surrounding soft tissue anywhere in the body. This provides a synthetic but biologically inert matrix that forms a bridge that channels new tissue into the existing environment. Already clinically explored for scar reduction / prevention in the world of surgical incisions, this technology has a plethora of clinical applications for healing tissues in other areas including the spine, cartilage and tendon.
Clinical Franchises 003
Tissue Spacing
Tissue Spacing products built upon the Tetramatrix™ platform were developed to create and maintain surgical space in the body to support a range of surgeries or medical interventions. Delivered by simple injection, these products remain visible to clinicians under multiple conditions while their structural stability, resorption and modularity fulfil a range of clinical needs from the optimisation of radiation therapy to microscopic cataract surgeries.
Clinical Franchises 004
Precision Medicine
Our initial Precision Medicine product (STEPP) is built upon the Tetramatrix™ platform creating a sprayable drug delivery system for intranasal delivery of active compounds to provide a clinically reproducible, minimally invasive and easy to use route of administration. STEPP has been shown in early clinical testing to protects the active compound, creates a sticky cushion on the nasal canal and helps to efficiently transport the active compounds into the blood stream.
Our Partnering Process
We partner with established medical companies to translate platform-derived products, using a staged approach that aligns early on fit and feasibility and progresses through readiness and supply.
Fit and feasibility
Together with our partners, we start by defining the use-case, intended role, practical delivery constraints and confirming commercial feasibility early. This helps confirm whether the product is a strong match with strong indications of impact before significant time and resources are committed.
Clear development
Partnership stages are structured so responsibilities, inputs, and decision points stay explicit from feasibility through readiness. We do the initial heavy lifting and take guidance from our partners to ensure full alignment. This supports smoother transitions into validation, scale-up, and ongoing supply expectations.
Commercialisation
Commercial execution is supported through partner capabilities, including market access, additional clinical pathways, and operational systems. This model is designed to maximise our partners’ customer engagement while we take care of final product manufacturing and supply.
Our Partnering Process
We partner with established medical companies to translate platform-derived products, using a staged approach that aligns early on fit and feasibility and progresses through readiness and supply.
Fit and feasibility
Together with our partners, we start by defining the use-case, intended role, practical delivery constraints and confirming commercial feasibility early. This helps confirm whether the product is a strong match with strong indications of impact before significant time and resources are committed.
Clear development
Partnership stages are structured so responsibilities, inputs, and decision points stay explicit from feasibility through readiness. We do the initial heavy lifting and take guidance from our partners to ensure full alignment. This supports smoother transitions into validation, scale-up, and ongoing supply expectations.
Commercialisation
Commercial execution is supported through partner capabilities, including market access, additional clinical pathways, and operational systems. This model is designed to maximise our partners’ customer engagement while we take care of final product manufacturing and supply.
Our Partnering Process
We partner with established medical companies to translate platform-derived products, using a staged approach that aligns early on fit and feasibility and progresses through readiness and supply.
Fit and feasibility
Together with our partners, we start by defining the use-case, intended role, practical delivery constraints and confirming commercial feasibility early. This helps confirm whether the product is a strong match with strong indications of impact before significant time and resources are committed.
Clear development
Partnership stages are structured so responsibilities, inputs, and decision points stay explicit from feasibility through readiness. We do the initial heavy lifting and take guidance from our partners to ensure full alignment. This supports smoother transitions into validation, scale-up, and ongoing supply expectations.
Commercialisation
Commercial execution is supported through partner capabilities, including market access, additional clinical pathways, and operational systems. This model is designed to maximise our partners’ customer engagement while we take care of final product manufacturing and supply.
© 2026 Tetratherix Limited
© 2026 Tetratherix Limited